MAX-40279 is primarily used as a selective inhibitor in biochemical research, particularly targeting specific kinases involved in cellular signaling pathways. It is applied in studies related to inflammation and immune response modulation due to its ability to suppress key pro-inflammatory mediators. Researchers utilize MAX-40279 to investigate pathway mechanisms in autoimmune diseases and cancer, where dysregulated kinase activity plays a critical role. Its high selectivity makes it a valuable tool for validating drug targets and assessing therapeutic potential in preclinical models. Additionally, MAX-40279 has been employed in pharmacokinetic and pharmacodynamic studies to support the development of more effective kinase-targeted therapies.